Product NDC: | 10019-953 |
Proprietary Name: | MESNA |
Non Proprietary Name: | MESNA |
Active Ingredient(s): | 100 mg/mL & nbsp; MESNA |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-953 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019884 |
Marketing Category: | NDA |
Start Marketing Date: | 19881230 |
Package NDC: | 10019-953-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (10019-953-01) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 10019-953-01 |
Proprietary Name | MESNA |
Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (10019-953-01) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 10019-953 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MESNA |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19881230 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | MESNA |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cytoprotective Agent [EPC] |